Patent application number | Description | Published |
20130054306 | CHURN ANALYSIS SYSTEM - A churn analysis system helps a business analyze, predict, and reduce customer churn. The system analyzes customer experiences by using an insightful block level approach to correlate customer experience with customer churn. Through the block level approach, the system is able to more accurately predict and effectively reduce future customer churn. As a result, businesses are able to reduce customer acquisition costs and improve customer retention rates. | 02-28-2013 |
20150078547 | CONNECTION ROUTING SYSTEM - According to an example, connections may be routed in a contact center by determining if a current connection from a customer terminal to the contact center is a repeat connection or a first connection. In response to determining that the connection is a repeat connection, the repeat connection is routed to an originating agent terminal when an originating agent is verified as employed, logged-in, and available. In response to determining that the connection is a first connection, the first connection is routed to a best available agent terminal. | 03-19-2015 |
20150135012 | NETWORK NODE FAILURE PREDICTIVE SYSTEM - In an example, network node failures may be predicted by extracting performance metrics for the network nodes from a plurality of data sources. A fail condition may be defined for the network nodes and input variables related to the fail condition for the network nodes may then be derived from the extracted performance metrics. A plurality of models may then be trained to predict the fail condition for the network nodes using a training set from the extracted performance metrics with at least one of the identified input variables. Each of the plurality of trained models may be validated using a validation set from the extracted performance metrics and may be rated according to predefined criteria. As a result, a highest rated model of the validated models may be selected to predict the fail condition for the network nodes. | 05-14-2015 |
Patent application number | Description | Published |
20140361349 | TRENCH SHIELD CONNECTED JFET - A shielded junction field effect transistor (JFET) is described having gate trenches and shield trenches, the shield trenches being deeper and narrower than the gate trenches. The gate trenches may be fully aligned, partially aligned, or separated from the shield trenches. | 12-11-2014 |
20150115289 | HYBRID WIDE-BANDGAP SEMICONDUCTOR BIPOLAR SWITCHES - A hybrid semiconductor bipolar switch in which a normally-on high-voltage wide-bandgap semiconductor bipolar switch and a normally-off field effect transistor are connected in a cascode (Baliga-pair) configuration. The switch may be constructed as a stacked hybrid device where a discrete transistor is bonded on top of a bipolar switch. Power systems may use plural switches paired with anti-parallel diodes. | 04-30-2015 |
20150200662 | Monolithically Integrated Cascode Switches - Disclosed inventions are directed to advanced high-voltage switches with improved performance characteristics, increased reliability, and better compatibility with conventional gate drivers. The inventions disclosed herein implement a hybrid switch, comprising a high-voltage normally-on SiC VJFET, controlled via a low-voltage Si MOSFET in a cascode (Baliga-pair) configuration. The SiC VJFET and Si MOSFET are integrated monolithically at a wafer level, with the Si MOSFET fabricated on the Si layer that is directly adjacent to a dielectric layer on top of the SiC VJFET. Methods of making and operating these switches are also provided. | 07-16-2015 |
20150214312 | TERMINATION STRUCTURE WITH MULTIPLE EMBEDDED POTENTIAL SPREADING CAPACITIVE STRUCTURES FOR TRENCH MOSFET - A termination structure with multiple embedded potential spreading capacitive structures (TSMEC) and method are disclosed for terminating an adjacent trench MOSFET atop a bulk semiconductor layer (BSL) with bottom drain electrode. The BSL has a proximal bulk semiconductor wall (PBSW) supporting drain-source voltage (DSV) and separating TSMEC from trench MOSFET. The TSMEC has oxide-filled large deep trench (OFLDT) bounded by PBSW and a distal bulk semiconductor wall (DBSW). The OFLDT includes a large deep oxide trench into the BSL and embedded capacitive structures (EBCS) located inside the large deep oxide trench and between PBSW and DBSW for spatially spreading the DSV across them. In one embodiment, the EBCS contains interleaved conductive embedded polycrystalline semiconductor regions (EPSR) and oxide columns (OXC) of the OFLDT, a proximal EPSR next to PBSW is connected to an active upper source region and a distal EPSR next to DBSW is connected to the DBSW. | 07-30-2015 |
Patent application number | Description | Published |
20090247434 | PREPARATION OF A MOLYBDENUM AMIDE ADDITIVE COMPOSITION AND THE LUBRICATING OIL COMPOSITIONS CONTAINING SAME - The invention is directed to oil soluble additive compositions, lubricating oil compositions, and additive concentrates comprising the salt of (1) a molybdenum oxide, sulfide, or oxysulfide and (2) an amide reaction product of a carboxylic acid component and a polyamine component wherein the charge mole ratio (CMR) of the carboxylic acid component to the polyamine component is about 2:1 to 1:1. | 10-01-2009 |
20100152079 | LUBRICATING OIL COMPOSITIONS CONTAINING A TETRAALKYL-NAPTHALENE-1,8 DIAMINE ANTIOXIDANT - Disclosed is a lubricating oil composition containing an oil of lubricating viscosity and a N,N,N′,N′-tetraalkyl-naphthalene-1,8-diamine and at least one additive selected from antioxidants, dispersants, and detergents which together provide superior oxidation inhibition and are suitable lubricants for automotive and truck crankcase lubricants; as well as transmission lubricants, gear lubricants, hydraulic fluids, compressor oils, diesel and marine lubricants. | 06-17-2010 |
20110077180 | PREPARATION OF A SULFURIZED MOLYBDENUM AMIDE COMPLEX AND ADDITIVE COMPOSITIONS HAVING LOW RESIDUAL ACTIVE SULFUR - The invention is directed to oil soluble additive compositions, lubricating oil compositions derived from a process for preparing a sulfurized oil soluble molybdenum complex having reduced active sulfur comprising: reacting an acidic molybdenum compound with an amide derived from a carboxylic acid component an polyamine component in a ratio from 2:1 to 1:1; there after sulfurizing to provide a sulfurized oil soluble molybdenum which is subsequently treated with at least one compound capable of reacting with the active sulfur of step b). | 03-31-2011 |
20110143979 | Lubricating oil compositions - A lubricating oil composition is disclosed which comprises (a) a major amount of an oil of lubricating viscosity; (b) one or more non-halogen-containing oil-soluble titanium complexes comprising at least one ligand comprising an anion of a carboxylic acid; (c) one or more dispersants; and (d) one or more detergents, wherein the lubricating oil composition is free of any zinc dialkyldithiophosphate. | 06-16-2011 |
20110143980 | Lubricating oil compositions containing titanium complexes - A lubricating oil composition is disclosed which comprises (a) a major amount of an oil of lubricating viscosity; and (b) one or more non-halogen-containing oil-soluble titanium complexes comprising at least one ligand selected from the group consisting of (i) an anion of an α-, β- or γ-hydroxycarbonyl compound; (ii) an anion of an α-, β- or γ-hydroxycarboxylic acid, amide or ester; (iii) an anion of an α-, β- or γ-aminocarboxylic acid; and (iv) an anion of an α-, β- or γ-keto acid. | 06-16-2011 |
20120077719 | PREPARATION OF A MOLYBDENUM IMIDE ADDITIVE COMPOSITION AND LUBRICATING OIL COMPOSITIONS CONTAINING SAME - The invention is directed to oil soluble additive compositions, lubricating oil compositions, and additive concentrates. The oil soluble additive composition comprises a salt or complex of (i) a molybdenum component which comprises a molybdenum oxide, sulfide, or oxysulfide of the general formula MoO | 03-29-2012 |
20120309654 | LUBRICATING OIL COMPOSITIONS CONTAINING TITANIUM COMPLEXES - A lubricating oil composition is disclosed which comprises (a) a major amount of an oil of lubricating viscosity; and (b) one or more non-halogen-containing oil-soluble titanium complexes comprising at least one ligand selected from the group consisting of (i) an anion of an α-, β- or γ-hydroxycarbonyl compound; (ii) an anion of an α-, β- or γ-hydroxycarboxylic acid, amide or ester; (iii) an anion of an α-, β- or γ-aminocarboxylic acid; and (iv) an anion of an α-, β- or γ-keto acid. | 12-06-2012 |
20130157913 | PREPARATION OF A POST-TREATED MOLYBDENUM AMIDE ADDITIVE COMPOSITION AND LUBRICATING OIL COMPOSITIONS CONTAINING SAME - The invention is directed to oil soluble additive compositions, lubricating oil compositions, and additive concentrates comprising the salt of (1) a molybdenum oxide, sulfide, or oxysulfide; (2) an amide reaction product of a carboxylic acid component and a polyamine component wherein the charge mole ratio (CMR) of the carboxylic acid component to the polyamine component is about 2:1 to 1:1; and (3) a post-treating agent. | 06-20-2013 |
20140018269 | POST-TREATED MOLYBDENUM IMIDE ADDITIVE COMPOSITION, METHODS OF MAKING SAME AND LUBRICATING OIL COMPOSITIONS CONTAINING SAME - The invention is directed to an oil soluble additive composition prepared by a process comprising reacting a molybdenum component; an imide derived from the reaction product of a hydrocarbyl dicarboxylic acid component and a polyamine component wherein the hydrocarbyl dicarboxylic acid component is the reaction product of a dicarboxylic acid component and a hydrocarbyl component; and a post-treating agent, thereby producing a post-treated molybdated succinimide additive composition. | 01-16-2014 |
20140179573 | POST-TREATED MOLYBDENUM IMIDE ADDITIVE COMPOSITION, METHODS OF MAKING SAME AND LUBRICATING OIL COMPOSITIONS CONTAINING SAME. - The invention is directed to an embodiment of the present invention is directed to an oil soluble additive composition prepared by a process comprising: reacting, (a) a molybdenum component; (b) an imide derived from the reaction product of a hydrocarbyl dicarboxylic acid component and a polyamine wherein said reaction product is prepared by first charging a polyamine to a reaction vessel and then charging a hydrocarbyl dicarboxylic acid component to the reaction vessel, wherein the charge mole ratio of the hydrocarbyl dicarboxylic acid component to the polyamine is from about 1:1 to about 1:0.5; and (c) a post-treating agent, thereby producing a post-treated moblydated succinimide additive composition. | 06-26-2014 |
20140206586 | LUBRICATING OIL COMPOSITIONS - A lubricating oil composition is disclosed which comprises (a) a major amount of an oil of lubricating viscosity; (b) one or more non-halogen-containing oil-soluble titanium complexes comprising at least one ligand comprising an anion of a carboxylic acid; (c) one or more dispersants; and (d) one or more detergents, wherein the lubricating oil composition is free of any zinc dialkyldithiophosphate. | 07-24-2014 |
20150111801 | LUBRICATING OIL COMPOSITION FOR PROTECTION OF SILVER BEARINGS IN MEDIUM SPEED DIESEL ENGINES - Provided herein is a medium speed diesel engine crankcase lubricating oil composition comprising:
| 04-23-2015 |
Patent application number | Description | Published |
20090307825 | STERILE GLOVE WITH TOUCHLESS DONNING - A sterile glove includes a cuff that has an inside surface and an outside surface. The cuff is folded over at a fold when the glove is packaged and when it is initially removed from the package. The glove further includes a hand and finger portion. The glove further includes a detachable tab that is coupled to the cuff and includes a free end. The detachable tab is adapted to facilitate a donning of the glove before being detached. | 12-17-2009 |
20100037365 | STERILE GLOVE WITH TOUCHLESS DONNING - A sterile glove includes a cuff that has an inside surface and an outside surface. The cuff is folded over at a fold when the glove is packaged and when it is initially removed from the package. The glove further includes a hand and finger portion. The glove further includes a detachable tab that is coupled to the cuff and includes a free end. The detachable tab is adapted to facilitate a donning of the glove before being detached. | 02-18-2010 |
20110138518 | STERILE GLOVE WITH TOUCHLESS DONNING - A sterile glove includes a hand and finger portion and a cuff having an inside surface and an outside surface. The cuff is adapted to be folded over at a fold when the glove is packaged in a sterile package and the fold forms an opening for inserting a hand into the glove. A stretching mechanism is coupled substantially near or on the fold and is adapted to increase a size of the opening while donning the glove. At least a portion of the stretching mechanism is detachable. The stretching mechanism has an unstretched state and a stretched state, and the stretching mechanism is in the unstretched state when the glove is packaged. | 06-16-2011 |
20120117711 | STERILE GLOVE WITH TOUCHLESS DONNING - A sterile glove that includes a hand and finger portion, a cuff having an inside surface and an outside surface, and a cuff rim. The cuff is adapted to be folded over at a fold when the glove is packaged, and a portion of the inside surface of the cuff becomes an outer facing surface when it is folded over. The glove further includes a detachable tab that is coupled to the inside surface and includes a free end and a non-free end. The glove further includes a detachable shield covering at least a portion of the outer facing surface when the cuff is folded over at the fold. | 05-17-2012 |
20140013484 | STERILE GLOVE WITH TOUCHLESS DONNING - A sterile glove that includes a hand and finger portion, a cuff having an inside surface and an outside surface, and a cuff rim. The cuff is adapted to be folded over at a fold when the glove is packaged, and a portion of the inside surface of the cuff becomes an outer facing surface when it is folded over. The glove further includes a detachable tab that is coupled to the inside surface and includes a free end and a non-free end. The glove further includes a detachable shield covering at least a portion of the outer facing surface when the cuff is folded over at the fold. | 01-16-2014 |
Patent application number | Description | Published |
20080200488 | Combinations Comprising a Protein Kinase Inhibitor Being a Pyrimidylaminobenzamide Compound and a Hsp90 Inhibitor Such as 17-Aag - The invention provides a pharmaceutical combination comprising:
| 08-21-2008 |
20080200489 | Combination of Organic Compounds - The invention provides a pharmaceutical combination comprising:
| 08-21-2008 |
20090215792 | METHOD OF TREATING CHRONIC MYELOGENOUS LEUKEMIA CELLS - Here, the inventors disclose the treatment of imatinib mesylate resistant chronic myelogenous leukemia cells with a cotreatment of vorinostat (SAHA, suberoylanilide hydroxamic acid) and dasatinib, a dual Abl/Src kinase (TK) inhibitor. Combined treatment of cultured human CML and BaF3 cells with vorinostat and dasatinib induced more apoptosis than either agent alone, as well as synergistically induced loss of clonogenic survival, which was associated with greater depletion of Bcr-Abl, p-CrkL and p-STAT5 levels. Co-treatment with dasatinib and vorinostat also attenuated the levels of Bcr-AblE255K and Bcr-AblT315I and induced apoptosis of BaF3 cells with ectopic expression of the mutant forms of Bcr-Abl. Finally, co-treatment of the primary CML cells with vorinostat and dasatinib induced more loss of cell viability and depleted Bcr-Abl or Bcr-AblT315I, p-STAT5 and p-CrkL levels than either agent alone. | 08-27-2009 |
20100227849 | LEUKEMIA TREATMENT METHOD AND COMPOSITION - A method of inducing high anti-leukemia activity responsive to the combination of hydroxamic acid analogue histone deacetylase inhibitors and PKC412 against human acute leukemia characterized as expressing phosphorylated (p)FLT3 kinase by a novel flow cytometry-based assay. | 09-09-2010 |
20130197017 | COMBINATIONS COMPRISING A PROTEIN KINASE INHIBITOR BEING A PYRIMIDYLAMINOBENZAMIDE COMPOUND AND A HSP90 INHIBITOR SUCH AS 17-11G - The invention provides a pharmaceutical combination comprising:
| 08-01-2013 |